Evaluating the serum fibrinogen level as a biomarker of disease severity in stable non-cystic fibrosis bronchiectasis Cover

.blurhash-client-img { display: none !important; }

Evaluating the serum fibrinogen level as a biomarker of disease severity in stable non-cystic fibrosis bronchiectasis

Volume 73 (2024): Issue 1 (January 2024)

By: Doaa Gadallah, Ahmed Tawfeek and Shimaa Nour Morsi

Open Access

|Apr 2025

Authors

Doaa Gadallah

drdoaagad@yahoo.com

Department of Chest Diseases, Sohag University, Sohag, Egypt

Ahmed Tawfeek

Department of Clinical Pathology, Sohag University, Sohag, Egypt

Shimaa Nour Morsi

Department of Chest Diseases, Sohag University, Sohag, Egypt

DOI: https://doi.org/10.2478/pneum-2025-0005 | Journal eISSN: 2247-059X | Journal ISSN: 2067-2993

Journal RSS Feed

Language: English

Page range: 26 - 35

Published on: Apr 24, 2025

Published by: Romanian Society of Pneumology

In partnership with: Paradigm Publishing Services

Publication frequency: Volume open

Keywords:

serum fibrinogen,

stable non-cystic fibrosis bronchiectasis,

bronchiectasis severity index

Related subjects:

Clinical medicine,

Clinical medicine, other,

Internal medicine,

© 2025 Doaa Gadallah, Ahmed Tawfeek, Shimaa Nour Morsi, published by Romanian Society of Pneumology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 73 (2024): Issue 1 (January 2024)Next article